Skip to Content
myAACR
Donate Today

Progress Against Cancer

Home » Patients, Caregivers, and Advocates » Progress Against Cancer » Research » Page 2

Recent Progress: FDA Approvals

Targeting Advanced Kidney Cancer 

Targeting Advanced Kidney Cancer 

The FDA approved the molecularly targeted therapeutic tivozanib to treat certain adult patients with the most common type of kidney cancer.  The U.S. Food and Drug Administration (FDA) has approved tivozanib (Fotivda) to treat...